Drug Profile
Aplaviroc
Alternative Names: 873140; AK 602; GW 873140; ONO-4128Latest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Developer GSK
- Class Antiretrovirals; Benzamides; Piperazines
- Mechanism of Action CCR5 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 13 Mar 2006 Discontinued - Phase-III for HIV infections treatment in USA (PO)
- 01 Feb 2006 Data presented at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2005) have been added to the drug interactions and Viral infections pharmacodynamics trials sections
- 13 Dec 2005 Data presented at the 10th European AIDS Conference (EACS-2005) have been added to the drug interactions and Viral infections antimicrobial activity sections ,